498 related articles for article (PubMed ID: 17186542)
41. Inhibition of the tumor-associated urokinase-type plasminogen activation system: effects of high-level synthesis of soluble urokinase receptor in ovarian and breast cancer cells in vitro and in vivo.
Magdolen V; Krüger A; Sato S; Nagel J; Sperl S; Reuning U; Rettenberger P; Magdolen U; Schmitt M
Recent Results Cancer Res; 2003; 162():43-63. PubMed ID: 12790320
[TBL] [Abstract][Full Text] [Related]
42. Expression of urokinase plasminogen activator and its receptor during acute renal allograft rejection.
Roelofs JJ; Rowshani AT; van den Berg JG; Claessen N; Aten J; ten Berge IJ; Weening JJ; Florquin S
Kidney Int; 2003 Nov; 64(5):1845-53. PubMed ID: 14531820
[TBL] [Abstract][Full Text] [Related]
43. Human breast adenocarcinoma cell lines promote angiogenesis by providing cells with uPA-PAI-1 and by enhancing their expression.
Bajou K; Lewalle JM; Martinez CR; Soria C; Lu H; Noël A; Foidart JM
Int J Cancer; 2002 Aug; 100(5):501-6. PubMed ID: 12124797
[TBL] [Abstract][Full Text] [Related]
44. A cleaved form of the receptor for urokinase-type plasminogen activator in invasive transplanted human and murine tumors.
Solberg H; Rømer J; Brünner N; Holm A; Sidenius N; Danø K; Høyer-Hansen G
Int J Cancer; 1994 Sep; 58(6):877-81. PubMed ID: 7927882
[TBL] [Abstract][Full Text] [Related]
45. Plasminogen activation in venous leg ulcers.
Herouy Y; Trefzer D; Hellstern MO; Stark GB; Vanscheidt W; Schöpf E; Norgauer J
Br J Dermatol; 2000 Nov; 143(5):930-6. PubMed ID: 11069499
[TBL] [Abstract][Full Text] [Related]
46. Evidence of a non-conventional role for the urokinase tripartite complex (uPAR/uPA/PAI-1) in myogenic cell fusion.
Bonavaud S; Charrière-Bertrand C; Rey C; Leibovitch MP; Pedersen N; Frisdal E; Planus E; Blasi F; Gherardi R; Barlovatz-Meimon G
J Cell Sci; 1997 May; 110 ( Pt 9)():1083-9. PubMed ID: 9175704
[TBL] [Abstract][Full Text] [Related]
47. Urokinase induces proliferation of human ovarian cancer cells: characterization of structural elements required for growth factor function.
Fischer K; Lutz V; Wilhelm O; Schmitt M; Graeff H; Heiss P; Nishiguchi T; Harbeck N; Kessler H; Luther T; Magdolen V; Reuning U
FEBS Lett; 1998 Oct; 438(1-2):101-5. PubMed ID: 9821967
[TBL] [Abstract][Full Text] [Related]
48. High tumor tissue concentration of urokinase plasminogen activator receptor is associated with good prognosis in patients with ovarian cancer.
Borgfeldt C; Bendahl PO; Gustavsson B; Långström E; Fernö M; Willén R; Grenman S; Casslén B
Int J Cancer; 2003 Nov; 107(4):658-65. PubMed ID: 14520707
[TBL] [Abstract][Full Text] [Related]
49. Urokinase-type plasminogen activator and its receptor in colorectal cancer: independent prognostic factors of metastasis and cancer-specific survival and potential therapeutic targets.
Yang JL; Seetoo Dq; Wang Y; Ranson M; Berney CR; Ham JM; Russell PJ; Crowe PJ
Int J Cancer; 2000 Sep; 89(5):431-9. PubMed ID: 11008205
[TBL] [Abstract][Full Text] [Related]
50. Stabilization of urokinase and urokinase receptor mRNAs by HuR is linked to its cytoplasmic accumulation induced by activated mitogen-activated protein kinase-activated protein kinase 2.
Tran H; Maurer F; Nagamine Y
Mol Cell Biol; 2003 Oct; 23(20):7177-88. PubMed ID: 14517288
[TBL] [Abstract][Full Text] [Related]
51. Urokinase receptor-dependent upregulation of smooth muscle cell adhesion to vitronectin by urokinase.
Chang AW; Kuo A; Barnathan ES; Okada SS
Arterioscler Thromb Vasc Biol; 1998 Dec; 18(12):1855-60. PubMed ID: 9848876
[TBL] [Abstract][Full Text] [Related]
52. Expression of UPA and UPAR is associated with the clinical course of urinary bladder neoplasms.
Seddighzadeh M; Steineck G; Larsson P; Wijkström H; Norming U; Onelöv E; Linder S
Int J Cancer; 2002 Jun; 99(5):721-6. PubMed ID: 12115506
[TBL] [Abstract][Full Text] [Related]
53. ELISA for complexes between urokinase-type plasminogen activator and its receptor in lung cancer tissue extracts.
de Witte H; Pappot H; Brünner N; Grøndahl-Hansen J; Hoyer-Hansen G; Behrendt N; Guldhammer-Skov B; Sweep F; Benraad T; Danø K
Int J Cancer; 1997 Jul; 72(3):416-23. PubMed ID: 9247284
[TBL] [Abstract][Full Text] [Related]
54. Expression of urokinase-type plasminogen activator, its receptor, and its inhibitor in gastric adenocarcinoma tissues.
Hong SI; Park IC; Son YS; Lee SH; Kim BG; Lee JI; Lee TW; Kook YH; Min YI; Hong WS
J Korean Med Sci; 1996 Feb; 11(1):33-7. PubMed ID: 8703368
[TBL] [Abstract][Full Text] [Related]
55. Vitronectin concentrates proteolytic activity on the cell surface and extracellular matrix by trapping soluble urokinase receptor-urokinase complexes.
Chavakis T; Kanse SM; Yutzy B; Lijnen HR; Preissner KT
Blood; 1998 Apr; 91(7):2305-12. PubMed ID: 9516128
[TBL] [Abstract][Full Text] [Related]
56. A competitive chromogenic assay to study the functional interaction of urokinase-type plasminogen activator with its receptor.
Rettenberger P; Wilhelm O; Oi H; Weidle UH; Goretzki L; Koppitz M; Lottspeich F; König B; Pessara U; Kramer MD
Biol Chem Hoppe Seyler; 1995 Oct; 376(10):587-94. PubMed ID: 8590627
[TBL] [Abstract][Full Text] [Related]
57. Regulation of mesothelial cell mitogenesis by antisense oligonucleotides for the urokinase receptor.
Shetty S; Kumar A; Johnson AR; Idell S
Antisense Res Dev; 1995; 5(4):307-14. PubMed ID: 8746780
[TBL] [Abstract][Full Text] [Related]
58. Plasminogen activator inhibitor 1 functions as a urokinase response modifier at the level of cell signaling and thereby promotes MCF-7 cell growth.
Webb DJ; Thomas KS; Gonias SL
J Cell Biol; 2001 Feb; 152(4):741-52. PubMed ID: 11266465
[TBL] [Abstract][Full Text] [Related]
59. Lysophosphatidylcholine induces urokinase-type plasminogen activator and its receptor in human macrophages partly through redox-sensitive pathway.
Oka H; Kugiyama K; Doi H; Matsumura T; Shibata H; Miles LA; Sugiyama S; Yasue H
Arterioscler Thromb Vasc Biol; 2000 Jan; 20(1):244-50. PubMed ID: 10634825
[TBL] [Abstract][Full Text] [Related]
60. Identification of a novel urokinase receptor splice variant and its prognostic relevance in breast cancer.
Luther T; Kotzsch M; Meye A; Langerholc T; Füssel S; Olbricht N; Albrecht S; Ockert D; Muehlenweg B; Friedrich K; Grosser M; Schmitt M; Baretton G; Magdolen V
Thromb Haemost; 2003 Apr; 89(4):705-17. PubMed ID: 12669126
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
